Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ANTM Stock Summary
In the News
LivaNova: Reaching End Of RECOVER And ANTHEM
LivaNova is approaching the end of the ANTHEM and RECOVER which could dramatically change the company profile. In cardiopulmonary results are great with a new product launch of Essenz taking market share at premium prices. Run-rate PEs aren't that high, and a languishing price means a setup here that could be attractive once the trials start to demonstrate concrete promise in 2024.
2 Healthcare Stocks That Could Help Set You Up for Life
These stocks could create significant wealth for shareholders in the long run.
Premiums, Deductibles, and Co-Pays: What Your Health Coverage Really Costs You
You're not entirely off the hook for healthcare costs after paying your insurance premiums. Here are a few other expenses to keep in mind.
Beyoncé's ‘Break My Soul' Heralded As Anthem For The Great Resignation
“Now I just fell in love/ And I just quit my job,” Beyoncé' sings on the dance track.
Anthem (ANTM) Unveils Two Brands to Boost Whole Person Health
Anthem (ANTM) launches Carelon and Wellpoint brands to streamline its products and services portfolio as well as bring about enhanced health plans for clients and consumers.
As Anthem Rebrands To Elevance, Healthcare Services To Be Named ‘Carelon'
Anthem's rebrand to Elevance Health will also include the new name of “Carelon” for its healthcare services and “Wellpoint” for certain health plans.
Anthem (ANTM) Ties Up to Improve Maternal Health Outcomes
Anthem (ANTM) teams up with Happify Health to bring a digital-first solution aimed at addressing issues stemming from the pregnancy experience and other health aspects of women.
Anthem (ANTM) Up 27% in a Year: Can It Retain the Momentum?
Anthem (ANTM) is well-poised for growth on sustained top-line improvement, membership increases in Government business and sturdy financial position.
5 HMO Stocks Set to Gain From Membership Growth, M&A Strategy
Rising membership and a rapidly growing aging U.S. population are likely to drive the performances of the Zacks Medical-HMO industry players. UNH, ANTM, HUM, CNC and SEM are poised to benefit from improved operational efficiencies.
Anthem's Gains Weaken The Bull Case
ANTM has returned 29% over the past year, as the company continues to turn in consensus-beating earnings. The Wall Street consensus outlook continues to be bullish, albeit with modest expectations implied by the 12-month price target.
ANTM Financial details
ANTM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 412.04 | 496.6 | 568.66 | 652.48 | 726.32 | |
Net income per share | 19.01 | 18.63 | 25.26 | 24.56 | 25.38 | |
Operating cash flow per share | 23.96 | 43.55 | 34.31 | 35 | 34.17 | |
Free cash flow per share | 19.71 | 39.39 | 29.85 | 30.2 | 28.68 | |
Cash per share | 97.37 | 118.88 | 127.76 | 138.91 | 153.2 | |
Book value per share | 125.45 | 135.28 | 147.91 | 151.28 | 166.62 | |
Tangible book value per share | 10.1 | 8.57 | 5.27 | 7.07 | 16.17 | |
Share holders equity per share | 125.45 | 135.28 | 147.91 | 151.28 | 166.62 | |
Interest debt per share | 82.36 | 84.84 | 97.74 | 104.02 | 110.85 | |
Market cap | 76.39B | 78.8B | 113.01B | 123.11B | 111.24B | |
Enterprise value | 91.54B | 93.09B | 131.16B | 139.84B | 129.84B | |
P/E ratio | 15.89 | 17.23 | 18.35 | 20.89 | 18.58 | |
Price to sales ratio | 0.73 | 0.65 | 0.82 | 0.79 | 0.65 | |
POCF ratio | 12.6 | 7.37 | 13.51 | 14.66 | 13.8 | |
PFCF ratio | 15.33 | 8.15 | 15.53 | 16.99 | 16.44 | |
P/B Ratio | 2.41 | 2.37 | 3.13 | 3.39 | 2.83 | |
PTB ratio | 2.41 | 2.37 | 3.13 | 3.39 | 2.83 | |
EV to sales | 0.88 | 0.76 | 0.95 | 0.89 | 0.76 | |
Enterprise value over EBITDA | 12.86 | 12.59 | 14.22 | 14.81 | 74.57 | |
EV to operating cash flow | 15.1 | 8.71 | 15.68 | 16.65 | 16.11 | |
EV to free cash flow | 18.37 | 9.63 | 18.02 | 19.3 | 19.19 | |
Earnings yield | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | |
Free cash flow yield | 0.07 | 0.12 | 0.06 | 0.06 | 0.06 | |
Debt to equity | 0.63 | 0.6 | 0.64 | 0.66 | 0.64 | |
Debt to assets | 0.26 | 0.23 | 0.24 | 0.23 | 0.23 | |
Net debt to EBITDA | 2.13 | 1.93 | 1.97 | 1.77 | 10.68 | |
Current ratio | 2.15 | 2.13 | 2.07 | 1.4 | 1.44 | |
Interest coverage | 8.02 | 7.96 | 9.93 | 9.13 | 0 | |
Income quality | 1.26 | 2.34 | 1.37 | 1.4 | 1.35 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.17 | 0.21 | 0.18 | 0.21 | 0.23 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.38 | 0.36 | 0.36 | 0.34 | 0.33 | |
Capex to operating cash flow | -0.18 | -0.1 | -0.13 | -0.14 | -0.16 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.95 | -0.88 | -0.83 | -0.69 | -0.74 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 231.61 | 238.14 | 289.93 | 289.12 | 308.46 | |
ROIC | 0.09 | 0.08 | 0.1 | 0.1 | 0 | |
Return on tangible assets | 0.1 | 0.08 | 0.1 | 0.09 | 0.08 | |
Graham Net | -109.56 | -135.24 | -160.76 | -111.24 | -182.92 | |
Working capital | 18.82B | 21.32B | 23.07B | 15.92B | 18.24B | |
Tangible asset value | 2.55B | 2.1B | 1.29B | 1.7B | 3.82B | |
Net current asset value | -10.55B | -13.28B | -16.59B | -10.76B | -9.49B | |
Invested capital | 0.63 | 0.6 | 0.64 | 0.66 | 0.64 | |
Average receivables | 9.93B | 10.76B | 12.2B | 14.74B | 16.95B | |
Average payables | 12.73B | 14.95B | 17.67B | 19.56B | 21.83B | |
Average inventory | -27.3B | -31.69B | -36.41B | -24.93B | -28.86B | |
Days sales outstanding | 36.96 | 32.82 | 35.38 | 37.4 | 38.06 | |
Days payables outstanding | 2.39K | 687.03 | 619.38 | 577.7 | 485.9 | |
Days of inventory on hand | -5.32K | -1.4K | -1.29K | -318.69 | -977.92 | |
Receivables turnover | 9.88 | 11.12 | 10.32 | 9.76 | 9.59 | |
Payables turnover | 0.15 | 0.53 | 0.59 | 0.63 | 0.75 | |
Inventory turnover | -0.07 | -0.26 | -0.28 | -1.15 | -0.37 | |
ROE | 0.15 | 0.14 | 0.17 | 0.16 | 0.15 | |
Capex per share | -4.26 | -4.16 | -4.46 | -4.8 | -5.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 167.8 | 177.57 | 184.58 | 182.1 | 182.98 | |
Net income per share | 3.99 | 8.37 | 7.83 | 5.48 | 3.67 | |
Operating cash flow per share | -6.38 | 27.24 | 8.24 | 11.1 | -12.75 | |
Free cash flow per share | -7.63 | 25.97 | 6.76 | 9.75 | -14.15 | |
Cash per share | 140.1 | 159.07 | 160.66 | 164.6 | 155.06 | |
Book value per share | 152.58 | 157.29 | 161.48 | 163.29 | 168.64 | |
Tangible book value per share | 7.13 | 5.36 | 9.87 | 11.72 | 16.37 | |
Share holders equity per share | 152.58 | 157.29 | 161.48 | 163.29 | 168.64 | |
Interest debt per share | 102.3 | 108.28 | 107.29 | 106.69 | 108.89 | |
Market cap | 122.07B | 109.2B | 105.12B | 102.45B | 109.91B | |
Enterprise value | 138.79B | 124.53B | 120.25B | 116.38B | 128.5B | |
P/E ratio | 32.16 | 13.73 | 14.18 | 19.87 | 32.1 | |
Price to sales ratio | 3.06 | 2.59 | 2.41 | 2.39 | 2.58 | |
POCF ratio | -80.41 | 16.88 | 53.91 | 39.21 | -36.99 | |
PFCF ratio | -67.22 | 17.71 | 65.7 | 44.66 | -33.34 | |
P/B Ratio | 3.36 | 2.92 | 2.75 | 2.67 | 2.8 | |
PTB ratio | 3.36 | 2.92 | 2.75 | 2.67 | 2.8 | |
EV to sales | 3.48 | 2.95 | 2.75 | 2.72 | 3.01 | |
Enterprise value over EBITDA | 99.07 | 40.42 | 41.84 | 55.95 | 286.19 | |
EV to operating cash flow | -91.43 | 19.25 | 61.67 | 44.54 | -43.25 | |
EV to free cash flow | -76.43 | 20.19 | 75.16 | 50.73 | -38.98 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
Free cash flow yield | -0.01 | 0.06 | 0.02 | 0.02 | -0.03 | |
Debt to equity | 0.66 | 0.68 | 0.66 | 0.65 | 0.64 | |
Debt to assets | 0.23 | 0.23 | 0.23 | 0.22 | 0.23 | |
Net debt to EBITDA | 11.94 | 4.97 | 5.27 | 6.69 | 41.41 | |
Current ratio | 1.4 | 1.43 | 1.44 | 1.41 | 1.44 | |
Interest coverage | 5.04 | 10.43 | 9.35 | 6.39 | 0.1 | |
Income quality | -1.58 | 3.23 | 1.05 | 2.01 | -3.58 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.32 | 0.18 | 0.19 | 0.27 | 0.4 | |
Sales general and administrative to revenue | 0.05 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.34 | 0.33 | 0.33 | 0.32 | 0.33 | |
Capex to operating cash flow | 0.2 | -0.05 | -0.18 | -0.12 | 0.11 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.63 | -0.65 | -0.81 | -0.75 | -0.77 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 117.01 | 172.16 | 168.68 | 141.87 | 118.05 | |
ROIC | 0.02 | 0.03 | 0.03 | 0.02 | 0 | |
Return on tangible assets | 0.01 | 0.03 | 0.03 | 0.02 | 0.01 | |
Graham Net | -112.19 | -116.76 | -102.14 | -163.01 | -201.6 | |
Working capital | 15.92B | 17.93B | 18.17B | 17.85B | 18.24B | |
Tangible asset value | 1.7B | 1.27B | 2.34B | 2.76B | 3.82B | |
Net current asset value | -10.76B | -11.76B | -11.11B | -10.75B | -9.49B | |
Invested capital | 0.66 | 0.68 | 0.66 | 0.65 | 0.64 | |
Average receivables | 15.13B | 16.38B | 16.62B | 16.73B | 17.4B | |
Average payables | 20.42B | 20.62B | 20.9B | 21.68B | 22.59B | |
Average inventory | -26.38B | -12.15B | -10.18B | -21.56B | -44.85B | |
Days sales outstanding | 36.16 | 35.66 | 34.05 | 35.56 | 37.7 | |
Days payables outstanding | 509.27 | 532.63 | 440.91 | 429.07 | 428.34 | |
Days of inventory on hand | -280.94 | -334.15 | -154.56 | -691.15 | -1K | |
Receivables turnover | 2.49 | 2.52 | 2.64 | 2.53 | 2.39 | |
Payables turnover | 0.18 | 0.17 | 0.2 | 0.21 | 0.21 | |
Inventory turnover | -0.32 | -0.27 | -0.58 | -0.13 | -0.09 | |
ROE | 0.03 | 0.05 | 0.05 | 0.03 | 0.02 | |
Capex per share | -1.25 | -1.27 | -1.48 | -1.36 | -1.4 |
ANTM Frequently Asked Questions
What is Anthem, Inc. stock symbol ?
Anthem, Inc. is a US stock , located in Indianapolis of Indiana and trading under the symbol ANTM
Is Anthem, Inc. buy or a sell ?
28 stock analysts have 28 predictions with a medium analyst target price of $519.29. The lowest prediction is $335 and the highest is $625
What is ANTM stock prediction ?
What is Anthem, Inc. stock quote today ?
Anthem, Inc. stock price is $- today.
Is Anthem, Inc. stock public?
Yes, Anthem, Inc. is a publicly traded company.